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Pattern of HIV-1 drug resistance mutations
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Background: HIV-1 Drug Resistance Mutations (DRMs) among
individuals with Immunological failure (IF) on different NRTI
based ﬁrst-line regimen, Thymidine analogue (TA) - AZT & D4T
and Non-Thymidine Analogue (NTA) -TDF; and predict viral drug
sucessibility to gain vision about optimal treatment strategies for
second-line.
Methods & Materials: Cross-sectionaly, 400 HIV-1 infected
patients, failingﬁrst-lineHAARTwere included in the analysis. HIV-
1 pol gene spanning 20 – 240 codons of Reverse Transcriptase was
genotyped by validated homebrew method and mutation pattern
was examined, (IAS-USA 2014 and Stanford HIV drug resistance
database v7.0)
Results: Out of 400, majority had subtype C infection 97.2%
(n=389) and any DRM was seen in n=379. On analyzing two
groups, duration of failure was longer for TA (n=279), with the
median of 57.6 (IQR 35.2-76.2) months compared to NTA (n=121),
24 (IQR 11.2-51.8) months, (p <0.05). Among individual mutation
analyzed K65R (23.2% vs. 4.6%), L74V (10.7% vs. 0.3%) and Y115F
(11.6% vs. 0.7%) was signiﬁcantly higher among NTA compared to
TA, (p <0.001); whereas M184V and TAM accumulation was sig-
niﬁcantly high in TA (p<0.05), Among NNRTI mutation K101E/P/H
(18.1% vs. 8.5%), G190A (32.7% vs. 27.6%) was higher among NVP
(p<0.05) and K103N (57% vs. 35.1%), V106M (30.2% vs. 12.1%) was
higher among EFV (p<0.05).
Based on themutation pattern observed in both groups,we ana-
lyzed the impact ofDRMson future therapyand foundas; in TAhigh
level of resistance was observed to all drugs, except TDF (71.5%)
>AZT (56.3%) >ABC (50%). In the same way among NTA AZT (78.6%)
>TDF (63.7%) and >ABC (38.1%) was observed. On combining both,
among TA failures still 56.7% and 71.4% can be considered for AZT
andTDFbased second-line. Similarly, amongNTA failures still 63.7%
and 78.6% can be considered for TDF and AZT based second-line
regimen.
Conclusion: As expected TA based ﬁrst-line failure had devel-
oped more cross resistance compared to NTA group, but still
majority can be recycled in the same regimen as second-line
option. Further, in resource limited settings, treatment outcome
is monitored immunologically; when virological based treatment
monitoring comes in practice further emergence of DRMs can be
avoided by early switching.
http://dx.doi.org/10.1016/j.ijid.2016.02.106
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The impact of HIV infection on the burden and
severity of inﬂuenza illness in Malawian adults
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Background: The impact of HIV infection on the incidence and
severity of inﬂuenza illness in adults in sub-Saharan Africa (SSA)
is unclear. Although annual seasonal inﬂuenza vaccination is rec-
ommended for HIV-infected persons in developed settings, it is not
part of routine HIV care in SSA.
Methods & Materials: At the Queen Elizabeth Central Hospital
in Blantyre, Malawi, we conducted: i) a prospective cohort study,
to compare the incidence of inﬂuenza illness betweenHIV-infected
and HIV-uninfected adults; ii) a case control study, to determine
risk factors for severe inﬂuenza presentation. Cases were adults
with severe inﬂuenza illness (lower respiratory tract infection
(LRTI) requiring hospitalization). Controls were adults with mild
inﬂuenza presentation (inﬂuenza-like illness (ILI) managed as out-
patients). Inﬂuenzawas identiﬁed fromnasopharyngeal specimens
by real-time reverse transcription polymerase chain reactions (RT-
PCR).
Results: The cohort study enrolled 360 HIV-infected (median
CD4 count 390 cells/cm3) and 248 HIV-uninfected adults, pro-
viding 520 and 348 person-years of observation, respectively.
Between April 2013 and March 2015, 24/229 (10.5%) ILI episodes
in HIV-infected and 5/119 (4.2%) in HIV-uninfected adults were
inﬂuenza PCR-positive. HIV-infected adults had almost three times
increased risk of laboratory-conﬁrmed inﬂuenza illness compared
to HIV-uninfected adults (incidence rates 46.0 vs. 14.5 per 1000
person-years; incidence rate ratio 2.75, 95% conﬁdence interval (CI)
1.02-7.44). In the case control study, 56/518 (10.8%) patients with
hospitalised LRTI, and 88/642 (13.7%) with ILI were inﬂuenza PCR-
positive. HIV prevalence among the inﬂuenza-positive cases and
controls were 70% and 30% respectively. On multivariable analy-
sis, HIV infection was the most important risk factor for severe
inﬂuenza presentations (odds ratio (OR) 4.98, 95%CI 2.09-11.88),
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with a population attributable fraction (PAF) of 57%. Unimproved
sanitation (OR 3.14, 95%CI 1.25-7.84) and food insecurity (OR
20.85, 95% CI 1.97-221.16) were also associated with hospitalised
inﬂuenza.
Conclusion: A substantial burden of inﬂuenza was identiﬁed in
bothHIV-infected anduninfectedMalawian adults.Moreover, HIV-
infected adults appear to have increased susceptibility and severity
of inﬂuenza presentations. Inﬂuenza vaccination in this at-risk
group is likely to be beneﬁcial. However, the optimal mechanism
for vaccine introduction and evaluation in already overstretched
health systems in SSA will need to be determined.
http://dx.doi.org/10.1016/j.ijid.2016.02.107
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Attenuated resting memory B cell compartment
in HIV infected children despite Highly Active
Antiretroviral Therapy (HAART)
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Background: Studies assessing the impact of Highly Active
Antiretroviral Therapy (HAART) on B cell subpopulations in HIV
infected children are scarce. Hence, we undertook this study to
describe the B cell compartment and the effect of HAART in a cohort
of HIV-infected children (<5 years of age).
Methods & Materials: Treatment-naïve HIV infected chil-
dren were enrolled and followed regularly till 12 months; HIV
uninfected children with no major illness were recruited as
healthy controls (n =51). CD10-CD20+ B cells were characterized
as naïve (CD21+CD27-), resting memory (21+CD27+), activated
memory (CD21-CD27+) and tissue like memory (CD21-CD27-) B
cells. The frequency of these B cell subpopulations was evalu-
ated in HIV-1 infected children at baseline, 6 months and 12
months of HAART. The percentage of B cell subpopulations at
baseline were compared between HIV infected and uninfected
children.
Results: Twenty-seven HIV-1 infected HAART naïve children
of median age 22 (12-44) months [boys: 63%] were enrolled. At
baseline,Marked differenceswere observed in B cell subpopulation
distribution amongHIV infected children and healthy controls. The
median frequencies ofnaïveBcells and restingmemoryBcellswere
signiﬁcantly lower (p =0.001; p=0.0005 respectively), while acti-
vatedmemory and tissue likememoryB cell poolwere signiﬁcantly
expanded in HIV infected children compared to healthy controls
(p <0.0001 for both). At 12 months of HAART, no signiﬁcant dif-
ferences were observed in the frequencies of naive (p =0.88) and
activated memory (p=0.13) B cells between HIV infected HAART
treated children and healthy controls. However, the frequency of
tissue like memory B cells was still signiﬁcantly higher in HIV
infected HAART treated children (p=0.001) and signiﬁcantly infe-
rior resting memory B cell pool was observed compared to their
healthy counterparts (p =0.002).
Conclusion: This study re-iterates the effectiveness of HAART
in pediatric population; however, it raises concern about the
inadequate reconstitution of B cell compartment at 12 months of
treatment.
http://dx.doi.org/10.1016/j.ijid.2016.02.108
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Background: Tuberculosis is one of the major global health
problems. The diagnosis of TB relies primarily on the identiﬁcation
of acid fast bacilli (AFB) by microscopy. Microscopic examination
of direct specimen smear stained with Ziehl-Neelsen (ZN) stain-
ing and studies have found this assay to be less sensitive. TB-Beads
can be used as an alternative to centrifugation for concentration
of TB bacilli. The current study intends to compare the conven-
tional specimen pre-treatment with the novel technique of sample
pre-treatment based on magnetic beads in single tube.
Methods & Materials: We evaluated the feasibility of a ligand-
coated magnetic bead technology to concentrate M. tuberculosis
in single tube (decontamination, concentration and staining) prior
to detection by LED-based ﬂuorescence microscopy. We compared
the quality of this method with the Ziehl-Neelsen (ZN) microscopy
performed after modiﬁed Petroff (MP) method and direct ﬂuores-
cencemicroscopy (FM) in sputumsamples at a reference laboratory
in India. The kappa coefﬁcient (Kc) analysis performed for positive
correlationbetween the tests andLJ culture takenas agold standard
for evaluation to sensitivity and speciﬁcity of performed tests.
Results: The head to head comparison on all performed tests
were performed, concentrated magnetic bead-FM possess higher
positivity rate (58.7%) than and direct microscopy (45.3%) and
MP-ZN microscopy (41%) among all 150 sputum samples. By com-
paring with culture the concentrated magnetic bead-FM (88.5%)
had signiﬁcantly higher sensitivity than MP-ZN (73%) and direct
FM (74.4%). The speciﬁcities of magnetic bead FM direct FM and
MP-ZN microscopy were 74%, 86% and 94% respectively. The fair
correlation found between culture and ZN microscopy (Kc =0.67),
magnetic bead-FM (Kc =0.62) and Kc =0.60 with direct FM.
Conclusion: Newer Magnetic bead concentration of Mycobac-
teria in clinical samples showed a signiﬁcant improvement in the
sensitivity of microscopy compared to direct FM and concentrated
ZN microscopy. These methods will be improving the diagnostic
performance of smear microscopy and reducing the tuberculosis
burden by single tube processing.
http://dx.doi.org/10.1016/j.ijid.2016.02.109
